首页>
外国专利>
Fadd proteins, phosphorylated p38-mapk and fasl as tumour markers
Fadd proteins, phosphorylated p38-mapk and fasl as tumour markers
展开▼
机译:Fadd蛋白,磷酸化的p38-mapk和fasl作为肿瘤标志物
展开▼
页面导航
摘要
著录项
相似文献
摘要
The application relates to the use of at least one protein selected from the group consisting of FADD proteins and phosphorylated p38-MAPK, as a marker for absence of in vivo tumour. This use may further be complemented by the use of the FasL protein as a marker for presence of in vivo tumour. The (respective) amount(s) of FADD proteins and phosphorylated p38-MAPK indeed decrease, sometimes up to zero, with tumour development, while FasL expression is gained. FADD proteins are secreted from out of the tumour cells into their extracellular environment. A low cellular amount and a high extracellular amount of FADD proteins are prognostic of resistance to chemotherapy.
展开▼